Big Blue's IBM Research and Watson divisions are teaming with several national consortia to unlock and share molecular and clinical coronavirus data on HPC platforms.
This new partnership between Harvard's Chan School of Public Health and the Human Vaccines Project seeks to apply AI and genomics to accelerate vaccine development.
The companies are looking to model gene expression signatures to predict treatments for gastric cancer and improve patient stratification methodologies.
Mayo Clinic Ventures and NTT Venture Capital have invested in the AI software developer to synthesize biomedical data for drug development and precision medicine.
The new system, called BODE 2, will launch at the end of this year and will replace the existing BODE for the analysis of "big omics" data for research.
Analyzing patient exome sequence data, investigators identified germline variants with apparent ties to estrogen receptor-positive breast cancer recurrence.
The "augmented intelligence" startup applies machine learning and contextual language processing to make sense of multi-omics datasets and inform drug discovery.
Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.
In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.
